Protoporphyria, Erythropoietic
Also known as: Erythropoietic Protoporphyria (EPP) / Erythropoietic Protoporphyria / Hereditary erythropoietic porphyria / Erythropoietic protoporphyria (disorder) / Ferrochelatase deficiency (disorder) / Ferrochelatase Deficiency / Porphyria non-acute
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB04931 | Afamelanotide | An injectable subcutaneous implant used to mitigate phototoxicity secondary to erythropoietic protoporphyria (EPP). |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB04931 | Afamelanotide | Melanocyte-stimulating hormone receptor | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB04931 | Afamelanotide | 2 | Completed | 1 |
| DB12426 | Bitopertin | 2 | Active Not Recruiting | 1 |
| DB00501 | Cimetidine | 2 | Recruiting | 1 |
| DB18007 | Dersimelagon | 2 | Completed | 1 |
| DB12426 | Bitopertin | 2 / 3 | Enrolling by Invitation | 1 |
| DB00375 | Colestipol | 2 / 3 | Completed | 1 |
| DB04931 | Afamelanotide | 3 | Completed | 4 |
| DB09485 | Cysteine | 3 | Completed | 1 |
| DB18007 | Dersimelagon | 3 | Recruiting | 1 |
| DB09485 | Cysteine | Not Available | Completed | 1 |
| DB13257 | Ferrous sulfate anhydrous | Not Available | Completed | 1 |
| DB00951 | Isoniazid | Not Available | Terminated | 1 |